Skip to main content

Advertisement

Table 3 The comparison of 5-year outcomes between the diabetic group and nondiabetic group

From: Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes

Clinical endpoint Overall (n = 1205) Crude HR (95% CI) Adjusted HR (95% CI)
No diabetes (n = 834) Diabetes (n = 371)
MACCE 281 (33.7) 128 (34.5) 1.075 (0.872–1.325) 1.012 (0.815–1.255)
Cardiac death/MI/stroke 111 (13.3) 46 (12.4) 0.976 (0.692–1.377) 0.869 (0.608–1.242)
All-cause death 80 (9.6) 32 (8.6) 0.935 (0.620–1.409) 0.785 (0.512–1.203)
Cardiac death 37 (4.4) 19 (5.1) 1.210 (0.696–2.104) 0.982 (0.549–1.757)
MI 58 (7.0) 22 (5.9) 0.884 (0.541–1.444) 0.855 (0.515–1.419)
Stroke 20 (2.4) 11 (3.0) 1.280 (0.613–2.671) 1.148 (0.540–2.440)
Unplanned revascularization 187 (22.4) 88 (23.7) 1.084 (0.841–1.396) 1.065 (0.826–1.374)
  1. CI confidence interval, HR hazard ratio, MACCE major adverse cardiac and cerebrovascular event, MI myocardial infarction